MiNK Therapeutics, Inc.
INKT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001840229
No open-market purchases or sales by MiNK Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.39M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding MiNK Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 31 | 1 | 26 | −4 |
| Shares | 898.7K | 87.2K | 846.6K | +35.1K (+4.3%) |
| Value | $847.8K | $82.8K | $632.3K | −$132.7K (−17.3%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held MiNK Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 88,126 | $66.1K | 0.00% |
| Two Sigma Securities, LLC | 11,937 | $8.95K | 0.00% |
| Greenwich Wealth Management LLC | 10,805 | $8.00K | 0.00% |
| Jaffetilchin Investment Partners, LLC | 1 | $1 | 0.00% |
Sold out (8)
Institutions that held MiNK Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Goldman Sachs Group Inc | 17,561 | $16.7K |
| Millennium Management LLC | 13,121 | $12.5K |
| Qube Research & Technologies Ltd | 1,941 | $1.84K |
| California State Teachers Retirement System | 1,548 | $1.47K |
| Camelot Portfolios, LLC | 205 | $195 |
| Harbor Investment Advisory, LLC | 5 | $5 |
| Assetmark, Inc | 1 | $1 |
| Royal Bank of Canada | 160 | $0 |
Not filed for Q3 2024 yet (1)
Institutions that held MiNK Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 87,196 | $82.8K |